Palantir Technologies (NasdaqGS:PLTR) Partners With Accenture, Drops From Russell Indexes

Simply Wall St

Palantir Technologies (NasdaqGS:PLTR) recently announced a significant partnership with Accenture Federal Services, aimed at enhancing AI deployment for the U.S. federal government. This event, coupled with their removal from the Russell Midcap Index, occurred against a backdrop of Palantir's share price rising 54% over the last quarter. The increase in Palantir's Q1 2025 net income and improved earnings per share, alongside a broader market rally where major indexes like the Nasdaq hit new highs, likely bolstered the company's stock performance. Additionally, Palantir's successful share repurchase and multiple strategic alliances further consolidated investor confidence.

We've identified 1 risk for Palantir Technologies that you should be aware of.

NasdaqGS:PLTR Earnings Per Share Growth as at Jun 2025

The end of cancer? These 24 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

Palantir Technologies has experienced a very large total shareholder return of 1310.36% over the past three years. This remarkable performance sets it apart, particularly as it surpassed both the US market and the Software industry, each respectively yielding returns of 13.7% and 19.2% over the last year.

The company's recent strategic initiatives, including its collaboration with Accenture, emphasize a strong focus on AI deployment, likely contributing to forecasts of a 22.4% increase in revenue and a 30.6% rise in earnings annually. These developments are expected to sustain its growth trajectory, potentially enhancing shareholder value further.

Palantir’s share price movement should be considered alongside the consensus analyst price target of US$101.32. Current trading suggests a discount, highlighting market confidence in the company’s growth prospects relative to its valuation estimates. This indicates a positive reception toward its recent announcements, despite being removed from the Russell Midcap Index.

Our valuation report unveils the possibility Palantir Technologies' shares may be trading at a premium.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Palantir Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com